Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

New details on the link between CVD & cancer | HeartFlow announces launch of AI offering

News You Need to Know Today
New details on the link between CVD & cancer | HeartFlow announces launch of AI offering
Wednesday, April 19, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

New details on the link between CVD and cancer, from a study of 27M patients

According to the large new study, published in JACC: CardioOncology, atherosclerotic CVD is associated with an especially high risk of cancer. 

READ MORE >
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
Share on Twitter Share on Facebook Share on Linkedin

New details on the link between CVD and cancer, from a study of 27M patients

Share on Twitter Share on Facebook Share on Linkedin
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
According to the large new study, published in JACC: CardioOncology, atherosclerotic CVD is associated with an especially high risk of cancer. 
READ MORE >

AI helps ID patients who would benefit most from strict blood pressure control

The study's findings suggest that AI can help clinicians provide more personalized care than ever before. 

READ MORE >
Blood pressure
Share on Twitter Share on Facebook Share on Linkedin

AI helps ID patients who would benefit most from strict blood pressure control

Share on Twitter Share on Facebook Share on Linkedin
Blood pressure
The study's findings suggest that AI can help clinicians provide more personalized care than ever before. 
READ MORE >

HeartFlow announces US launch of AI-powered solution for evaluating coronary arteries

The AI-powered tool gained FDA clearance back in October 2022. 

READ MORE >
#ACC23 #ACC #Heartflow
Share on Twitter Share on Facebook Share on Linkedin

HeartFlow announces US launch of AI-powered solution for evaluating coronary arteries

Share on Twitter Share on Facebook Share on Linkedin
#ACC23 #ACC #Heartflow
The AI-powered tool gained FDA clearance back in October 2022. 
READ MORE >

Featured Articles

NSAID use, even for just 2 weeks, increases heart failure risk among patients with type 2 diabetes

The link between NSAIDs such as ibuprofen and heart failure was especially strong among patients 80 years old and older. For patients 65 years old and younger, on the other hand, no such link was identified. 

READ MORE >
cardiologist doctor physician patient black diverse hypertension
Share on Twitter Share on Facebook Share on Linkedin

NSAID use, even for just 2 weeks, increases heart failure risk among patients with type 2 diabetes

Share on Twitter Share on Facebook Share on Linkedin
cardiologist doctor physician patient black diverse hypertension
The link between NSAIDs such as ibuprofen and heart failure was especially strong among patients 80 years old and older. For patients 65 years old and younger, on the other hand, no such link was identified. 
READ MORE >

ACS and revascularization after TAVR: New data on a high-risk scenario

“It is vital to identify patients who are at a high risk for ACS after TAVR for potential treatment beforehand,” according a new analysis published in the American Journal of Cardiology.

READ MORE >
American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification.
Share on Twitter Share on Facebook Share on Linkedin

ACS and revascularization after TAVR: New data on a high-risk scenario

Share on Twitter Share on Facebook Share on Linkedin
American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification.
“It is vital to identify patients who are at a high risk for ACS after TAVR for potential treatment beforehand,” according a new analysis published in the American Journal of Cardiology.
READ MORE >

New technique improves accuracy of near-infrared fluorescence imaging

NIRF imaging could help interventional cardiologists personalize care in the cath lab, but a key engineering issue needed to be solved first.

READ MORE >
The variable fluorescence attenuation of blood has been a hindrance to near-infrared fluorescence (NIRF) measurements in cardiovascular imaging. Fortunately, researchers have devised an innovative correction method in which the guidewire (GW) is coated with the fluorescent agent (ICG) and used as a reference standard in each frame, leading to a much higher accuracy. Credit: Rauschendorfer et al., doi 10.1117/1.JBO.28.4.046001
Share on Twitter Share on Facebook Share on Linkedin

New technique improves accuracy of near-infrared fluorescence imaging

Share on Twitter Share on Facebook Share on Linkedin
The variable fluorescence attenuation of blood has been a hindrance to near-infrared fluorescence (NIRF) measurements in cardiovascular imaging. Fortunately, researchers have devised an innovative correction method in which the guidewire (GW) is coated with the fluorescent agent (ICG) and used as a reference standard in each frame, leading to a much higher accuracy. Credit: Rauschendorfer et al., doi 10.1117/1.JBO.28.4.046001
NIRF imaging could help interventional cardiologists personalize care in the cath lab, but a key engineering issue needed to be solved first.
READ MORE >

In Case You Missed It

Antibiotic recalled due to risk of endocarditis, other life-threatening infections

According to an advisory on the FDA’s website, there is a “reasonable probability” that any immunocompromised patients exposed to the affected antibiotic could develop a life-threatening infection.

READ MORE >
FDA Recall
Share on Twitter Share on Facebook Share on Linkedin

Antibiotic recalled due to risk of endocarditis, other life-threatening infections

Share on Twitter Share on Facebook Share on Linkedin
FDA Recall
According to an advisory on the FDA’s website, there is a “reasonable probability” that any immunocompromised patients exposed to the affected antibiotic could develop a life-threatening infection.
READ MORE >

Intravascular imaging-guided PCI boosts outcomes, but utilization remains low

Eric Secemsky, MD, told Cardiovascular Business that a lack of training is one of the biggest factors limiting the use of intravascular imaging-guided PCI among interventional cardiologists. 

READ MORE >
Eric Secemsky, MD, FACC, FAHA, FSCAI, FSVM, director of vascular intervention at Beth Israel Deaconess Medical Center, Boston, Massachusetts, presented the results of a real-world evidence study of data for over 1 million U.S. Medicare patients to evaluate trends in the use of, and outcomes associated with, intravascular imaging during percutaneous coronary interventions (PCI). #IVUS
Share on Twitter Share on Facebook Share on Linkedin

Intravascular imaging-guided PCI boosts outcomes, but utilization remains low

Share on Twitter Share on Facebook Share on Linkedin
Eric Secemsky, MD, FACC, FAHA, FSCAI, FSVM, director of vascular intervention at Beth Israel Deaconess Medical Center, Boston, Massachusetts, presented the results of a real-world evidence study of data for over 1 million U.S. Medicare patients to evaluate trends in the use of, and outcomes associated with, intravascular imaging during percutaneous coronary interventions (PCI). #IVUS
Eric Secemsky, MD, told Cardiovascular Business that a lack of training is one of the biggest factors limiting the use of intravascular imaging-guided PCI among interventional cardiologists. 
READ MORE >

In Other News

Poverty is a leading cause of death

Poverty was associated with 183,000 deaths in the United States in 2019 among people 15 years and older, according to a recent study published in JAMA. 

READ MORE >
Homeless man
Share on Twitter Share on Facebook Share on Linkedin

Poverty is a leading cause of death

Share on Twitter Share on Facebook Share on Linkedin
Homeless man
Poverty was associated with 183,000 deaths in the United States in 2019 among people 15 years and older, according to a recent study published in JAMA. 
READ MORE >

4 policy levers politicians can pull to address private equity’s growing interest in radiology

Harvard Medical School experts believe U.S. regulators need more firepower to begin better understanding the impact of such trends. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

4 policy levers politicians can pull to address private equity’s growing interest in radiology

Share on Twitter Share on Facebook Share on Linkedin
Harvard Medical School experts believe U.S. regulators need more firepower to begin better understanding the impact of such trends. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …1055
    • Page 1056
    • Page 1057
    • Page 1058
    • Current page 1059
    • Page 1060
    • Page 1061
    • Page 1062
    • Page 1063 …
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup